NCT04953962 2023-08-15
Study of CBP501/Cisplatin/Nivolumab Combinations in Advanced Pancreatic Cancer
CanBas Co. Ltd.
Phase 2 Completed
Clinical Trials
5 trialsNCT00700336 2021-07-20
Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II)
CanBas Co. Ltd.
Phase 1/2 Completed
NCT03113188 2021-03-10
CBP501, Cisplatin and Nivolumab in Advanced Refractory Tumors
CanBas Co. Ltd.
Phase 1 Completed
NCT00942825 2017-05-24
CBP08-02
CanBas Co. Ltd.
Phase 2 Completed
NCT00551512 2017-03-14
Phase I Study of CBP501 and Cisplatin in Patients With Advanced Refractory Solid Tumors
CanBas Co. Ltd.
Phase 1 Completed